Development of intravenously administered synthetic RNA virus immunotherapy for the treatment of cancerEdward M. Kennedy, Lorena Lerner|Nature Communications|2022Cited by 40
Development of intravenously administered synthetic RNA virus immunotherapy for the treatment of cancerEdward M. Kennedy, Lorena Lerner|Research Square|2021Cited by 4